fibrinogen has been researched along with Small Cell Lung Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Li, K; Meng, Z; Wang, J; Wang, X; Zhang, C | 1 |
| An, G; Fan, S; Guan, Y; Zhao, G | 1 |
| Chen, P; Jiang, Q; Li, J; Tang, XP; Zhu, LR | 1 |
1 trial(s) available for fibrinogen and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer.
Topics: Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Fibrinogen; gamma-Glutamyltransferase; Humans; Indoles; Lactate Dehydrogenases; Lung Neoplasms; Phosphopyruvate Hydratase; Progression-Free Survival; Quinolines; Small Cell Lung Carcinoma; Treatment Outcome | 2021 |
2 other study(ies) available for fibrinogen and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma.
Topics: Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2018 |
Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoassay; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Small Cell Lung Carcinoma | 2016 |